168 related articles for article (PubMed ID: 2829751)
1. Cutaneous responses to 12-hydroxy-5,8,10,14-eicosatetraenoic acid (12-HETE) and 5,12-dihydroxyeicosatetraenoic acid (leukotriene B4) in psoriasis and normal human skin.
Dowd PM; Black AK; Woollard PW; Greaves MW
Arch Dermatol Res; 1987; 279(7):427-34. PubMed ID: 2829751
[TBL] [Abstract][Full Text] [Related]
2. Antiinflammatory effects of second-generation leukotriene B4 receptor antagonist, SC-53228: impact upon leukotriene B4- and 12(R)-HETE-mediated events.
Fretland DJ; Anglin CP; Bremer M; Isakson P; Widomski DL; Paulson SK; Docter SH; Djuric SW; Penning TD; Yu S
Inflammation; 1995 Apr; 19(2):193-205. PubMed ID: 7601505
[TBL] [Abstract][Full Text] [Related]
3. 15-hydroxyeicosatetraenoic acid (15-HETE) specifically inhibits the LTB4-induced skin response.
Ternowitz T; Andersen PH; Bjerring P; Fogh K; Schröder JM; Kragballe K
Arch Dermatol Res; 1989; 281(6):401-5. PubMed ID: 2556975
[TBL] [Abstract][Full Text] [Related]
4. SC-41930 inhibits neutrophil infiltration of the cavine dermis induced by 12(R)-hydroxyeicosatetraenoic acid.
Fretland DJ; Widomski DL; Shone RL; Penning TD; Miyashiro JM; Djuric SW
Prostaglandins Leukot Essent Fatty Acids; 1989 Dec; 38(3):169-72. PubMed ID: 2560200
[TBL] [Abstract][Full Text] [Related]
5. Response of psoriatic lesions to multiple applications of leukotriene B4 and 12-HETE.
Norris PG; Schofield O; Dowd PM; Greaves MW
Dermatologica; 1987; 174(5):219-23. PubMed ID: 3034690
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous responses to 12-hydroxy-5,8,10,14-eicosatetraenoic acid (12-HETE).
Dowd PM; Kobza Black A; Woollard PM; Camp RD; Greaves MW
J Invest Dermatol; 1985 Jun; 84(6):537-41. PubMed ID: 3998504
[TBL] [Abstract][Full Text] [Related]
7. Contrasting in vitro lymphocyte chemotactic activity of the hydroxyl enantiomers of 12-hydroxy-5,8,10,14-eicosatetraenoic acid.
Bacon KB; Camp RD; Cunningham FM; Woollard PM
Br J Pharmacol; 1988 Nov; 95(3):966-74. PubMed ID: 2850067
[TBL] [Abstract][Full Text] [Related]
8. 12(R)-hydroxy-5,8,10,14-eicosatetraenoic acid is a chemoattractant for human polymorphonuclear leucocytes in vitro.
Cunningham FM; Woollard PM
Prostaglandins; 1987 Jul; 34(1):71-8. PubMed ID: 3317516
[TBL] [Abstract][Full Text] [Related]
9. 12(S)-hydroxy-5,8,10,14-eicosatetraenoic acid is a more potent neutrophil chemoattractant than the 12(R) epimer in the rat cornea.
Wiggins RE; Jafri MS; Proia AD
Prostaglandins; 1990 Aug; 40(2):131-41. PubMed ID: 2171040
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the proinflammatory effects of 12(R)- and 12(S)-hydroxy-5,8,10,14-eicosatetraenoic acid in human skin.
Wollard PM; Cunnigham FM; Murphy GM; Camp RD; Derm FF; Greaves MW
Prostaglandins; 1989 Oct; 38(4):465-71. PubMed ID: 2813813
[TBL] [Abstract][Full Text] [Related]
11. The chemokinetic response of psoriatic and normal polymorphonuclear leukocytes to arachidonic acid lipoxygenase products.
Cunningham FM; Wong E; Woollard PM; Greaves MW
Arch Dermatol Res; 1986; 278(4):270-3. PubMed ID: 3017241
[TBL] [Abstract][Full Text] [Related]
12. 6-trans-leukotriene B4 is a neutrophil chemotaxin in the guinea pig dermis.
Fretland DJ; Widomski DL; Anglin CP; Walsh RE; Levin S; Gaginella TS
J Leukoc Biol; 1991 Mar; 49(3):283-8. PubMed ID: 1847716
[TBL] [Abstract][Full Text] [Related]
13. In vitro synthesis of 12-hydroxy-eicosatetraenoic acid is increased in uninvolved psoriatic epidermis.
Kragballe K; Desjarlais L; Duell EA; Voorhees JJ
J Invest Dermatol; 1986 Jul; 87(1):47-52. PubMed ID: 3088130
[TBL] [Abstract][Full Text] [Related]
14. Fifteen-S-hydroxyeicosatetraenoic acid (15-S-HETE) specifically antagonizes the chemotactic action and glomerular synthesis of leukotriene B4 in the rat.
Fischer DB; Christman JW; Badr KF
Kidney Int; 1992 May; 41(5):1155-60. PubMed ID: 1319518
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of human neutrophils by 5-oxo-6,8,11,14-eicosatetraenoic acid by a mechanism independent of the leukotriene B4 receptor.
Powell WS; Gravel S; MacLeod RJ; Mills E; Hashefi M
J Biol Chem; 1993 May; 268(13):9280-6. PubMed ID: 8387490
[TBL] [Abstract][Full Text] [Related]
16. 15-Hydroxyeicosatetraenoic acid (15-HETE) specifically inhibits LTB4-induced chemotaxis of human neutrophils.
Ternowitz T; Fogh K; Kragballe K
Skin Pharmacol; 1988; 1(2):93-9. PubMed ID: 2856182
[TBL] [Abstract][Full Text] [Related]
17. SC-41930, a leukotriene B4 receptor antagonist, inhibits 12(S)-hydroxyeicosatetraenoic acid (12(S)-HETE) binding to epidermal cells.
Kemény L; Ruzicka T
Agents Actions; 1991 Mar; 32(3-4):339-42. PubMed ID: 1650525
[TBL] [Abstract][Full Text] [Related]
18. Biosynthesis of lipoxygenase products by enzyme preparations from normal and psoriatic skin.
Ziboh VA; Casebolt TL; Marcelo CL; Voorhees JJ
J Invest Dermatol; 1984 Dec; 83(6):426-30. PubMed ID: 6094672
[TBL] [Abstract][Full Text] [Related]
19. Activation of neutrophil chemotaxis by leukotriene B4 and 5-hydroxyeicosatetraenoic acid in chronic inflammatory bowel disease.
Nielsen OH; Elmgreen J
Scand J Clin Lab Invest; 1987 Oct; 47(6):605-11. PubMed ID: 2823370
[TBL] [Abstract][Full Text] [Related]
20. Leukotriene B4 fails to induce penetration of polymorphonuclear leukocytes into psoriatic lesions.
Lammers AM; van de Kerkhof PC
Br J Dermatol; 1987 Nov; 117(5):541-4. PubMed ID: 2825753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
